当科の研究が英文誌「Cardiovascular Diabetology」に掲載されました。
Fumika Shigiyama, Naoki Kumashiro, Ayako Fuchigami and Takahisa Hirose
Rationale and design of study of dapagliflozin versus sitagliptin treatment efficacy on prevention of cardiovascular risk factors in type 2 diabetes patients: the DIVERSITY-CVR study.
Cardiovascular Diabetology 2018,17:86.
Cardiovascular Diabetology 2018,17:86.
